Where2invest personal page - To The Moon

Where2invest

Where2invest

No personal profile

14Follow

0Followers

0Topic

0Badge

2021-05-21

Wow

Bitcoin hovers above $40,000 after a wild week that saw the cryptocurrency plunge 30% at one point

2021-05-21

Wow

Sorry, the original content has been removed

2021-05-14

Hmmm

Why everyone from Elon Musk to Janet Yellen is worried about bitcoin’s energy usage

2021-05-09

Wow

Sorry, the original content has been removed

2021-05-09

Wow

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

2021-05-04

Wow

Sorry, the original content has been removed

2021-05-03

Wow

Uber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week

2021-05-01

Wow

3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street

2021-05-01

Wow

Sorry, the original content has been removed

2021-05-01

Wow

Europe's antitrust crackdown on Apple hints at what's coming for the company in the U.S.

2021-05-01

Comment and like

Sorry, the original content has been removed

2021-04-29

Comment pls

Sorry, the original content has been removed

2021-04-29

To the moon

Sorry, the original content has been removed

2021-03-22

Wow

Some “meme” stocks are slipping

2021-03-21

Wow

Sorry, the original content has been removed

2021-03-21

Hmmm

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3575490875523733,"uuid":"3575490875523733","gmtCreate":1612396852070,"gmtModify":1616328673652,"name":"Where2invest","pinyin":"where2invest","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":14,"tweetSize":16,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":139371588,"gmtCreate":1621596563444,"gmtModify":1704360277216,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/139371588","repostId":"1139943283","repostType":4,"repost":{"id":"1139943283","pubTimestamp":1621595661,"share":"https://ttm.financial/m/news/1139943283?lang=&edition=fundamental","pubTime":"2021-05-21 19:14","market":"us","language":"en","title":"Bitcoin hovers above $40,000 after a wild week that saw the cryptocurrency plunge 30% at one point","url":"https://stock-news.laohu8.com/highlight/detail?id=1139943283","media":"CNBC","summary":"Bitcoin’s price hovered above the $40,000 level on Friday, as a comeback for the world’s top cryptoc","content":"<div>\n<p>Bitcoin’s price hovered above the $40,000 level on Friday, as a comeback for the world’s top cryptocurrency was checked by worries around regulation.\nThe digital coin was up 1.7% at a price of $40,841...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/21/bitcoin-hovers-above-40000-mark-as-regulatory-concerns-cap-gains.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin hovers above $40,000 after a wild week that saw the cryptocurrency plunge 30% at one point</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin hovers above $40,000 after a wild week that saw the cryptocurrency plunge 30% at one point\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-21 19:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/21/bitcoin-hovers-above-40000-mark-as-regulatory-concerns-cap-gains.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bitcoin’s price hovered above the $40,000 level on Friday, as a comeback for the world’s top cryptocurrency was checked by worries around regulation.\nThe digital coin was up 1.7% at a price of $40,841...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/21/bitcoin-hovers-above-40000-mark-as-regulatory-concerns-cap-gains.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust","PYPL":"PayPal","SQ":"Block","COIN":"Coinbase Global, Inc."},"source_url":"https://www.cnbc.com/2021/05/21/bitcoin-hovers-above-40000-mark-as-regulatory-concerns-cap-gains.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1139943283","content_text":"Bitcoin’s price hovered above the $40,000 level on Friday, as a comeback for the world’s top cryptocurrency was checked by worries around regulation.\nThe digital coin was up 1.7% at a price of $40,841 by 6 a.m. ET, according to Coin Metrics data. It bounced above the $42,000 mark Thursday as digital currencies attempted to rebound from a brutal sell-off earlier in the week.\nOther cryptocurrencies were in the red Friday, with ether down 2.2% at $2,741, XRP off by 4.6% at $1.13 and litecoin falling 2.4% to $206. Dogecoin, a meme-inspired crypto supported by Tesla CEO Elon Musk, was down 2.6% at 39 cents.\nBitcoin’s gains were capped Friday after the U.S. Treasury Department said a day earlier that it would require any cryptocurrency transfer worth $10,000 or more to be reported to the Internal Revenue Service.\n“Cryptocurrency already poses a significant detection problem by facilitating illegal activity broadly including tax evasion,” the Treasury said.\nIt’s the latest sign of an impending regulatory crackdown on cryptocurrencies. Earlier this week, China issued a warning reiterating its stance that financial institutions and payment firms are forbidden from providing crypto-related services.\ntcoin and other cryptocurrencies slid as much as 30%on Wednesday, as investors reacted to the statement from China as well as mixed signals from Tesla CEO Elon Musk.\nMusk came out as a supporter of bitcoin earlier this year, with Tesla buying $1.5 billion worth of the cryptocurrency and briefly accepting it as a means of payment. However, he halted the purchase of Tesla vehicles with bitcoin last week, citing concerns over bitcoin’s huge energy consumption.\nCritics have long warned about bitcoin’s environmental impact. The cryptocurrency uses as much electricity as entire countries like the United Arab Emirates and Pakistan, according to Cambridge University researchers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139371184,"gmtCreate":1621596540548,"gmtModify":1704360276407,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/139371184","repostId":"1196025603","repostType":4,"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":198304850,"gmtCreate":1620922683970,"gmtModify":1704350606417,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/198304850","repostId":"1116555518","repostType":4,"repost":{"id":"1116555518","pubTimestamp":1620913985,"share":"https://ttm.financial/m/news/1116555518?lang=&edition=fundamental","pubTime":"2021-05-13 21:53","market":"us","language":"en","title":"Why everyone from Elon Musk to Janet Yellen is worried about bitcoin’s energy usage","url":"https://stock-news.laohu8.com/highlight/detail?id=1116555518","media":"cnbc","summary":"KEY POINTS\n\nElon Musk said Tesla had halted purchases of vehicles with bitcoin due to concerns over ","content":"<div>\n<p>KEY POINTS\n\nElon Musk said Tesla had halted purchases of vehicles with bitcoin due to concerns over the “rapidly increasing use of fossil fuels for bitcoin mining.”\nThe cryptocurrency uses more energy...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/13/why-elon-musk-is-worried-about-bitcoin-environmental-impact.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why everyone from Elon Musk to Janet Yellen is worried about bitcoin’s energy usage</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy everyone from Elon Musk to Janet Yellen is worried about bitcoin’s energy usage\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-13 21:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/13/why-elon-musk-is-worried-about-bitcoin-environmental-impact.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nElon Musk said Tesla had halted purchases of vehicles with bitcoin due to concerns over the “rapidly increasing use of fossil fuels for bitcoin mining.”\nThe cryptocurrency uses more energy...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/13/why-elon-musk-is-worried-about-bitcoin-environmental-impact.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust"},"source_url":"https://www.cnbc.com/2021/05/13/why-elon-musk-is-worried-about-bitcoin-environmental-impact.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1116555518","content_text":"KEY POINTS\n\nElon Musk said Tesla had halted purchases of vehicles with bitcoin due to concerns over the “rapidly increasing use of fossil fuels for bitcoin mining.”\nThe cryptocurrency uses more energy than entire countries such as Sweden and Malaysia, according to researchers.\nTreasury Secretary Janet Yellen has also warned about bitcoin’s environmental impact, saying it uses a “staggering” amount of power.\n\nElon Musk’sdecision to stopTeslafrom acceptingbitcoinas payment has led to fresh scrutiny of the cryptocurrency’s environmental impact.\nMusksaid Wednesdaythat Tesla had halted purchases of its vehicles with bitcoin due to concerns over the “rapidly increasing use of fossil fuels for bitcoin mining.”\nHe alluded to data from researchers at Cambridge University which shows bitcoin’s electricity usage spiking this year.\nTesla won't sell its bitcoin — the automaker is sitting on$2.5 billion worthof the digital coin — and Musk said it intends to resume transactions with bitcoin once mining \"transitions to more sustainable energy.\"\n\"We are also looking at other cryptocurrencies that use <1% of Bitcoin's energy/transaction,\" Musk said.\nMusk's comments roiled cryptocurrency markets, which haveshed as much as $365.85 billion in valuesince his tweet.\nWhy is Musk worried?\nCritics ofbitcoinhave long been wary of its impact on the environment. The cryptocurrency uses more energy than entire countries such as Sweden and Malaysia, according to the Cambridge Bitcoin Electricity Consumption Index.\nTo understand why bitcoin is so energy-intensive, you have to look at its underlying technology, the blockchain.\nBitcoin's public ledger is decentralized, meaning it isn't controlled by any single authority. It's constantly being updated by a network of computers around the world.\nSo-called miners run purpose-built computers to solve complex math puzzles in order to make a transaction go through. This is the only way to mint new bitcoins.\nMiners do not run this operation for free. They have to shell out huge sums on specialized equipment. A key incentive of bitcoin's model, known as \"proof of work,\" is the promise of being rewarded in some bitcoin if you manage to solve its complex hashing algorithm.\nIt's worth noting thatdogecoin, which has risen wildly in price lately on the back of support from Musk, also uses a proof-of-work mechanism.\nCarol Alexander, a professor at the University of Sussex Business School, explains that bitcoin's mining \"difficulty\" — a measure of the computational effort it takes to mine bitcoin — has been going \"up and up\" over the last three years.\n\"More and more electricity is being used,\" Alexander told CNBC. \"That means that the network difficulty will also be going up (and) more miners are coming in because the hash rate's going up.\"\nBitcoin's price is up almost 70% so far this year. As it goes up in price, the revenue to miners also increases, incentivizing more participants to mine the cryptocurrency.\nMeanwhile, Musk isn't the only one who's worried about the environmental impact of bitcoin. In February, Treasury Secretary Janet Yellen warned that the digital coin is \"extremely inefficient\" for making transactions and uses a \"staggering\" amount of power.\nDoes bitcoin actually harm the environment?\nIt's complicated. On the one hand, bitcoin's network uses anunfathomable amount of energy. Much of the mining of bitcoin is concentrated in China, whose economy is still heavily reliant on coal.\nLast month, a coal mine in the Xinjiang region flooded and shut down. This took nearly a quarter of bitcoin's hash rate — or computing power — offline, according to crypto industry publicationCoinDesk.\nIn March, China's Inner Mongolia region said it wouldshut down cryptocurrency mining operationsin the region due to concerns over energy consumption.\nOn the other side of the debate, bitcoin investors have attempted to push back on the narrative that it's harmful for the environment.\nWhile it's difficult to determine the energy mix that powers bitcoin, some in the crypto industry say miners are incentivized to use renewables as it's getting cheaper to produce them. In China, the province of Sichuan is known to attract miners due to its cheap electricity and rich hydropower resources.\nLast month,Jack Dorsey'sfintech companySquareand Cathie Wood's Ark Invest put out amemoclaiming that bitcoin will actually drive renewable energy innovation. However, critics said they had avested interestin doing so.\nAlexander said the debate around bitcoin's environmental impact was misguided as most transactions with the digital asset aren't happening on the blockchain.\n\"Almost all the trading is not done on the blockchain,\" she said. \"It's done on secondary markets, centralized exchanges. They're not even recorded on the blockchain.\"\nESG concerns\nRegardless of whether bitcoin is actually a polluter or not, the negative connotations around its energy consumption have worried investors conscious of companies' ethical and environmental responsibilities.\nESG, or environmental, social and corporate governance, has become agrowing trendin financial markets, with portfolio managers increasingly incorporating sustainable investments into their strategies.\nSome Tesla shareholders may be worried that the company is betting big on bitcoin while also claiming to be a green energy company.\n\"Bitcoin backers will be wondering where this leaves the future of the cryptocurrency,\" Laith Khalaf, a financial analyst at investment firm AJ Bell, said in a note Thursday.\n\"Environmental matters are an incredibly sensitive subject right now, and Tesla's move might serve as a wake-up call to businesses and consumers using Bitcoin, who hadn't hitherto considered its carbon footprint,\" Khalaf added.\n\"Tesla's decision certainly puts pressure on other big companies who accept Bitcoin to review their practices, because boardrooms will now be wary about getting it in the ear from ESG investors on the shareholder register.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190950426,"gmtCreate":1620573862065,"gmtModify":1704345091309,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190950426","repostId":"1170905579","repostType":4,"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190950664,"gmtCreate":1620573837358,"gmtModify":1704345091792,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190950664","repostId":"1147179681","repostType":4,"repost":{"id":"1147179681","pubTimestamp":1620458192,"share":"https://ttm.financial/m/news/1147179681?lang=&edition=fundamental","pubTime":"2021-05-08 15:16","market":"us","language":"en","title":"The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More","url":"https://stock-news.laohu8.com/highlight/detail?id=1147179681","media":"Benzinga","summary":"This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, ","content":"<p>This was an eventful week for the cannabis industry.</p><p>On Monday,<b>Tilray, Inc.</b>(NASDAQ:TLRY) and&nbsp;<b>Aphria, Inc.</b>(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion.</p><p>Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.</p><p><b>Jazz Pharmaceuticals</b>(NASDAQ:JAZZ) finalized its acquisition of&nbsp;<b>GW Pharmaceuticals plc.</b>(NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion&nbsp;net of GW Pharma's cash.</p><p>Meanwhile,<b>Ascend Wellness Holdings</b>(CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.</p><p>After two weeks of consolidating below resistance at the $1&nbsp;level, shares of Reddit favorite&nbsp;<b><a href=\"https://laohu8.com/S/SNDL\">Sundial Growers Inc.</a></b>&nbsp;have resumed their downtrend.</p><p><b><a href=\"https://laohu8.com/S/CS\">Credit Suisse Group AG</a></b>(NYSE:CS)&nbsp;reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.</p><p>The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States. While it's not yet clear what impact this decision will have, Reuters reported&nbsp;the move has affected the sale of marijuana stocks in recent weeks.</p><p>In fact, all major ETFs were down. Over the five trading days of this week:</p><ul><li>The<b><a href=\"https://laohu8.com/S/MJX\">ETFMG Alternative Harvest ETF</a></b>(NYSE:MJ): lost 0.2%.</li><li>The<b>$AdvisorShares Pure <a href=\"https://laohu8.com/S/THCX\">Cannabis ETF</a>(YOLO)$</b>(NYSE:YOLO): tumbled 1.8%.</li><li>The<b><a href=\"https://laohu8.com/S/MSOS\">AdvisorShares Pure US Cannabis ETF</a></b>(NYSE:MSOS): shed 0.2% of its value.</li><li>The<b><a href=\"https://laohu8.com/S/THCX\">Cannabis ETF</a></b>(NYSE:THCX): dropped 3.4%.</li><li>The<b>Amplify Seymour Cannabis ETF</b>(NYSE:CNBS): was down 3.5%.</li><li>The<b>SPDR S&amp;P 500 ETF Trust</b>(NYSE:SPY) closed the week up 1.21%.</li></ul><p><b>Policy, Science And Data</b></p><p>In <a href=\"https://laohu8.com/S/NWY\">New York</a>, people gathered to celebrate cannabis legalization.</p><p>“Last weekend's annual <a href=\"https://laohu8.com/S/NYRT\">New York</a> <a href=\"https://laohu8.com/S/CHCO\">City</a> cannabis parade brought out a who's who in politicians jockeying for position to be the <a href=\"https://laohu8.com/S/AONE\">one</a> who was<i>always</i>supportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,” commented Debra Borchardt, CEO ofGreen Market Report. “With adult use cannabis sales likely to be legal by next year's parade, the people who attended were clearly in a celebratory mood. The <a href=\"https://laohu8.com/S/NGD\">New</a> York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.”</p><p>In ColoradoGov. Jared Polis signed a bill that would expand&nbsp;access to medical cannabis for school children in need by removing obstacles to its administration.</p><p><b>Financings And M&amp;A</b></p><p><b>Jushi Holdings Inc.</b>(CSE:JUSH) (OTC:JUSHF) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary,<b>Dalitso LLC</b>, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William <a href=\"https://laohu8.com/S/ICBK\">County</a>, Virginia.</p><p><b>High Tide Inc.</b>(TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will acquire 80% of<b>Fab Nutrition, LLC</b>. (operating as FABCBD) for $20.64 million in stock and cash.</p><p><b>MassRoots, Inc.</b>(OTC:MSRT) is looking to acquire<b><a href=\"https://laohu8.com/S/NYNY\">Empire</a> Services, Inc</b>. for $14 million in a primarily stock-based transaction.</p><p><b>Trulieve Cannabis Corp</b>. (CSE:TRUL) (OTCQX:TCNNF) purchased <a href=\"https://laohu8.com/S/WSTC\">West</a> Virginia-based<b>Mountaineer Holding LLC</b>for $6 million.</p><p><b>Cansortium Inc.</b>(CSE:TIUM), (OTCQB:CNTMF), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.</p><p><b><a href=\"https://laohu8.com/S/GNBC\">Green</a> Thumb Industries Inc.</b>(CSE:GTII) (OTCQX:GTBIF) will reach the Virginia market via its acquisition of<b>Dharma Pharmaceuticals LLC.</b></p><p><b>Earnings Reports</b></p><p><b>Kiaro Holdings Corp.</b>(TSXV:KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. Same-store sales spiked 58% over the same period.</p><p><b>Cansortium Inc.</b>(CSE:TIUM) (OTCQB:CNTMF), which operates under the Fluent brand, announced&nbsp;its fourth-quarter and full-year 2020 financial results, with consolidated revenue of $14.7 million for the three months ending Dec. 31, up 54% year-over-year.</p><p><b>Scotts Miracle-Gro</b>&nbsp;(NYSE:SMG) reported that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales&nbsp;posted a year ago.</p><p>Sales for the cannabis-focused Hawthorne segment climbed up to $363.8 million, representing a 66% year-over-year increase.</p><p><b>Lowell Farms Inc.</b>(CSE:LOWL) (OTCQX:LOWLF) generated $11 million in revenue during the first quarter of the 2021 fiscal year, representing an increase of 17% year-over-year.</p><p>Cannabis REIT<b>Innovative Industrial Properties, Inc.</b>(NYSE:IIPR) announced its total revenue increased by 103% year-over-year to $42.9 million in the first quarter of 2021. Net income for the same period was roughly $25.6 million, or $1.05 per diluted share, representing an annual growth of 122%.</p><p><b>POSaBIT Systems Corporation</b>(CSE:PBIT) (OTCQX:POSAF) reported its total revenue increased by 327% year-over-year, hitting roughly $3.06 million in the fourth quarter of 2020. <a href=\"https://laohu8.com/S/TSS\">Total</a> revenue amounted to $7.82 million in 2020, representing an annual increase of 127%.</p><p><b>Cronos Group Inc</b>&nbsp;(NASDAQ:&nbsp;CRON)&nbsp;reported a Q1 adjusted EBITDA loss&nbsp;of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&amp;D costs.</p><p>Hemp cultivation and processing brand<b>HempFlax</b>posted its full-year 2020 earnings report, with revenues of €14.5 million ($17.4 million), up 43% from 2019's $10.1 million. EBITDA increased 63% from 2019, totaling €1.8 million, marking the company's second profitable year. EBITDA margins increased to 12.7% from the previous year's 11.1%.</p><p><b>Planet 13 Holdings Inc.</b>(CSE:PLTH) (OTCQX:PLNHF) generated record sales in April&nbsp;of $10.7 million —&nbsp;almost as much as last year’s total second-quarter revenue of $10.8 million.</p><p><b>Other News</b></p><p>Canadian hospital&nbsp;<b>Sunnybrook Health Sciences Centre</b>&nbsp;and&nbsp;<b>Avicana Inc</b>(OTC:AVCNF) announced a partnership to provide medical cannabis products on-site through the Odette Cancer Centre Pharmacy.</p><p><b>Orchid Ventures Inc</b>(OTC:ORVRD) entered an exclusive licensing agreement with&nbsp;<b>Gold Flora</b>. Per the agreement, Gold Flora will be assuming all production, sales, and distribution of Orchid Essentials products throughout the state of California, and purchasing all hardware, packaging, and terpenes through PurTecDelivery Systems, a wholly-owned subsidiary of Orchid Ventures.</p><p>“As <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest growth operators in the state, we are confident that Gold Flora's leadership and quality of their operations will accelerate Orchid's growth potential, further establishing the brand as a leader in the largest recreational cannabis market in the world, California,” Corey Mangold, CEO and chairman of Orchid Ventures, told Benzinga.</p><p><b><a href=\"https://laohu8.com/S/APDN\">Applied DNA Sciences</a>, Inc.</b>(NASDAQ:APDN) signed a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) with a maximal value of $1.04 million.</p><p><b>MedMen Enterprises Inc</b>(CSE:MMEN) (OTC:MMNFF) announced the opening of its first Miami Beach, Florida location.</p><p><b>Tamerlane Trading</b>launched an online quality-verified marketplace for wholesale and bulk cannabis, calling the move the first and only cannabis marketplace of its kind in the world.</p><p>“Our overall goal with the new online marketplace is to establish trust and transparency in the cannabis industry. By including quality verification and grading of cannabis product, wholesale buyers and suppliers will benefit,” said Jhavid Mohseni, CEO of Tamerlane Trading.</p><p><b>Acreage Holdings, Inc.</b>(CSE:ACRG) (OTC:ACRGF) and<b>Medterra CBD, LLC</b>are joining forces to develop a CBD-based collection of products.</p><p><b>Sitka Hash House</b>has launched its handmade hashish-based products into the California market with manufacturing partner, Garden Society. Founded in 2012, Sitka claims 9 out of the top 10 hashish SKUs in <a href=\"https://laohu8.com/S/WASH\">Washington</a> state.</p><p>Sitka CEO Jeff <a href=\"https://laohu8.com/S/GHC\">Graham</a> told Benzinga, “Interstate expansion offers us the opportunity to provide our original cannabis concentrates to new audiences. We are proud to enter California with the Garden Society as our manufacturer and HERBL as our distributor.”</p><p>The Aster Farms team tracked their energy consumption, CO2e emissions, water use, solid waste as well as their hiring practices over the last year. The company now released its first annual Sustainability Report.</p><p>“Sustainability is part of our company's DNA,” shared Aster Farms CEO and co-founder Julia Jacbonson. “From regenerative agriculture and recyclable packaging to inclusive hiring practices, we understand that sustainable farming is only part of the story.”</p><p>“The cannabis industry is in a unique position to change the paradigm of what a successful company looks and feels like and what is considered most important,” she added.</p><p>Newly released podcast<b>Highly Unlikely,</b>hosted by standup comedian<b>Alex Gettlin</b>and produced by Wikileaf, dives into the absurdity of the world we live in. Each episode features famed comedian guests losing their minds over some very real and strange facts while trying various new cannabis products.</p><p>Canadian licensed cannabis producers and global markets will have access to time-tested, feminized, organic-certified cannabis seeds. This is thanks to a new partnership between<b>Humboldt Seed Company</b>and<b>Nymera,</b>which will allow not only the production and sale of the seeds in Canada, but also the export of these genetics to other countries with legal cannabis markets around the world.</p><p>This is the first time a cannabis seed is certified as organic.</p><p><b>Calyxt</b>announced advancements in technology that will make it easier for scientists to bring advanced breeding into hemp. The company, an expert at improving crops like soybeans and wheat to produce more heart-healthy oil or higher fiber, announced its scientists have transformed hemp – an important step as the company can now engineer the hemp genome, unlocking capabilities to selectively breed and deliver improvements in hemp traits through advanced plant breeding like gene editing or even GM level engineering.</p><p>“We were able to change the plants DNA and regenerate plants through tissue culture, thus accomplishing something that has been fairly elusive in hemp to date,\"&nbsp;said Travis Frey, Ph.D., chief technology officer of Calyxt. “By modernizing the hemp crop, we can now deliver traits that benefits both growers and consumers who are increasingly looking for plant-based and sustainable foods, materials, cosmeceuticals, nutraceuticals and more.\"</p><p><b>Zelira Therapeutics Ltd</b>(ASX:ZLD) (OTCQB:ZLDAF) launched its HOPE line of cannabis products in <a href=\"https://laohu8.com/S/WRE\">Washington</a> DC. The product line, especially formulated for autism spectrum disorder (ASD) patients of all ages, is also available in Pennsylvania, Louisiana and Australia.</p><p>“Since we first launched HOPE in the US, our long-term goal has been to make it accessible to ASD patients everywhere, and <a href=\"https://laohu8.com/S/WASH\">Washington</a> DC's reciprocity allows us to take a huge step in that direction here in the US,” Dr. Oludare Odumosu, CEO of Zelira Therapeutics, told Benzinga. “The nation's capital is <a href=\"https://laohu8.com/S/AONE\">one</a> of the most popular travel destinations, so we are thrilled to be able to offer HOPE there as a treatment option for ASD patients from around the country who travel to DC.”</p><p><b>Cannabics Pharmaceuticals Inc.</b>(OTCQB:CNBX), received a “Notice of Allowance” from the Mexican Patent and Trademark Office (IMPI) for a patent on a “System and method for high throughput screening of cancer cells.”</p><p>Executive Moves</p><p>CBD products distributor,<b>Khode LLC.</b>, announced Tuesday&nbsp;it&nbsp;formed its first board of directors consisting of music artists, executives and CBD industry veterans, including Grammy award-winning artists and entrepreneur<b>DJ Khaled</b>, music executive<b>Lenny S</b>, CEO of<b>Endexx Corporation</b>(OTC:EDXC)<b>Todd Davis</b>, and<b>Stephen Herron</b>and<b>Ron Cotting</b>of<b>CBD Unlimited, Inc</b>.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 15:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, Inc.(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a ...</p>\n\n<a href=\"https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APHA":"Aphria Inc.","GTBIF":"Green Thumb Industries Inc.","SPY":"标普500ETF","THCX":"Innovation Shares Cannabis ETF","TLRY":"Tilray Inc.","GWPH":"GW Pharmaceuticals plc","CNBX":"CNBX Pharmaceuticals Inc.","NGD":"New Gold","CNBS":"Amplify Seymour Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","JAZZ":"爵士制药","CNTMF":"Cansortium Inc.","TCNNF":"Trulieve Cannabis Corporation","SNDL":"SNDL Inc.","YOLO":"AdvisorShares Pure Cannabis ETF","JUSHF":"Jushi Holdings Inc.","MSRT":"MassRoots, Inc.","MJ":"Amplify Alternative Harvest ETF"},"source_url":"https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147179681","content_text":"This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, Inc.(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion.Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.Jazz Pharmaceuticals(NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceuticals plc.(NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma's cash.Meanwhile,Ascend Wellness Holdings(CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.After two weeks of consolidating below resistance at the $1 level, shares of Reddit favorite Sundial Growers Inc. have resumed their downtrend.Credit Suisse Group AG(NYSE:CS) reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the United States. While it's not yet clear what impact this decision will have, Reuters reported the move has affected the sale of marijuana stocks in recent weeks.In fact, all major ETFs were down. Over the five trading days of this week:TheETFMG Alternative Harvest ETF(NYSE:MJ): lost 0.2%.The$AdvisorShares Pure Cannabis ETF(YOLO)$(NYSE:YOLO): tumbled 1.8%.TheAdvisorShares Pure US Cannabis ETF(NYSE:MSOS): shed 0.2% of its value.TheCannabis ETF(NYSE:THCX): dropped 3.4%.TheAmplify Seymour Cannabis ETF(NYSE:CNBS): was down 3.5%.TheSPDR S&P 500 ETF Trust(NYSE:SPY) closed the week up 1.21%.Policy, Science And DataIn New York, people gathered to celebrate cannabis legalization.“Last weekend's annual New York City cannabis parade brought out a who's who in politicians jockeying for position to be the one who wasalwayssupportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,” commented Debra Borchardt, CEO ofGreen Market Report. “With adult use cannabis sales likely to be legal by next year's parade, the people who attended were clearly in a celebratory mood. The New York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.”In ColoradoGov. Jared Polis signed a bill that would expand access to medical cannabis for school children in need by removing obstacles to its administration.Financings And M&AJushi Holdings Inc.(CSE:JUSH) (OTC:JUSHF) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary,Dalitso LLC, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William County, Virginia.High Tide Inc.(TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will acquire 80% ofFab Nutrition, LLC. (operating as FABCBD) for $20.64 million in stock and cash.MassRoots, Inc.(OTC:MSRT) is looking to acquireEmpire Services, Inc. for $14 million in a primarily stock-based transaction.Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) purchased West Virginia-basedMountaineer Holding LLCfor $6 million.Cansortium Inc.(CSE:TIUM), (OTCQB:CNTMF), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.Green Thumb Industries Inc.(CSE:GTII) (OTCQX:GTBIF) will reach the Virginia market via its acquisition ofDharma Pharmaceuticals LLC.Earnings ReportsKiaro Holdings Corp.(TSXV:KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. Same-store sales spiked 58% over the same period.Cansortium Inc.(CSE:TIUM) (OTCQB:CNTMF), which operates under the Fluent brand, announced its fourth-quarter and full-year 2020 financial results, with consolidated revenue of $14.7 million for the three months ending Dec. 31, up 54% year-over-year.Scotts Miracle-Gro (NYSE:SMG) reported that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales posted a year ago.Sales for the cannabis-focused Hawthorne segment climbed up to $363.8 million, representing a 66% year-over-year increase.Lowell Farms Inc.(CSE:LOWL) (OTCQX:LOWLF) generated $11 million in revenue during the first quarter of the 2021 fiscal year, representing an increase of 17% year-over-year.Cannabis REITInnovative Industrial Properties, Inc.(NYSE:IIPR) announced its total revenue increased by 103% year-over-year to $42.9 million in the first quarter of 2021. Net income for the same period was roughly $25.6 million, or $1.05 per diluted share, representing an annual growth of 122%.POSaBIT Systems Corporation(CSE:PBIT) (OTCQX:POSAF) reported its total revenue increased by 327% year-over-year, hitting roughly $3.06 million in the fourth quarter of 2020. Total revenue amounted to $7.82 million in 2020, representing an annual increase of 127%.Cronos Group Inc (NASDAQ: CRON) reported a Q1 adjusted EBITDA loss of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&D costs.Hemp cultivation and processing brandHempFlaxposted its full-year 2020 earnings report, with revenues of €14.5 million ($17.4 million), up 43% from 2019's $10.1 million. EBITDA increased 63% from 2019, totaling €1.8 million, marking the company's second profitable year. EBITDA margins increased to 12.7% from the previous year's 11.1%.Planet 13 Holdings Inc.(CSE:PLTH) (OTCQX:PLNHF) generated record sales in April of $10.7 million — almost as much as last year’s total second-quarter revenue of $10.8 million.Other NewsCanadian hospital Sunnybrook Health Sciences Centre and Avicana Inc(OTC:AVCNF) announced a partnership to provide medical cannabis products on-site through the Odette Cancer Centre Pharmacy.Orchid Ventures Inc(OTC:ORVRD) entered an exclusive licensing agreement with Gold Flora. Per the agreement, Gold Flora will be assuming all production, sales, and distribution of Orchid Essentials products throughout the state of California, and purchasing all hardware, packaging, and terpenes through PurTecDelivery Systems, a wholly-owned subsidiary of Orchid Ventures.“As one of the highest growth operators in the state, we are confident that Gold Flora's leadership and quality of their operations will accelerate Orchid's growth potential, further establishing the brand as a leader in the largest recreational cannabis market in the world, California,” Corey Mangold, CEO and chairman of Orchid Ventures, told Benzinga.Applied DNA Sciences, Inc.(NASDAQ:APDN) signed a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) with a maximal value of $1.04 million.MedMen Enterprises Inc(CSE:MMEN) (OTC:MMNFF) announced the opening of its first Miami Beach, Florida location.Tamerlane Tradinglaunched an online quality-verified marketplace for wholesale and bulk cannabis, calling the move the first and only cannabis marketplace of its kind in the world.“Our overall goal with the new online marketplace is to establish trust and transparency in the cannabis industry. By including quality verification and grading of cannabis product, wholesale buyers and suppliers will benefit,” said Jhavid Mohseni, CEO of Tamerlane Trading.Acreage Holdings, Inc.(CSE:ACRG) (OTC:ACRGF) andMedterra CBD, LLCare joining forces to develop a CBD-based collection of products.Sitka Hash Househas launched its handmade hashish-based products into the California market with manufacturing partner, Garden Society. Founded in 2012, Sitka claims 9 out of the top 10 hashish SKUs in Washington state.Sitka CEO Jeff Graham told Benzinga, “Interstate expansion offers us the opportunity to provide our original cannabis concentrates to new audiences. We are proud to enter California with the Garden Society as our manufacturer and HERBL as our distributor.”The Aster Farms team tracked their energy consumption, CO2e emissions, water use, solid waste as well as their hiring practices over the last year. The company now released its first annual Sustainability Report.“Sustainability is part of our company's DNA,” shared Aster Farms CEO and co-founder Julia Jacbonson. “From regenerative agriculture and recyclable packaging to inclusive hiring practices, we understand that sustainable farming is only part of the story.”“The cannabis industry is in a unique position to change the paradigm of what a successful company looks and feels like and what is considered most important,” she added.Newly released podcastHighly Unlikely,hosted by standup comedianAlex Gettlinand produced by Wikileaf, dives into the absurdity of the world we live in. Each episode features famed comedian guests losing their minds over some very real and strange facts while trying various new cannabis products.Canadian licensed cannabis producers and global markets will have access to time-tested, feminized, organic-certified cannabis seeds. This is thanks to a new partnership betweenHumboldt Seed CompanyandNymera,which will allow not only the production and sale of the seeds in Canada, but also the export of these genetics to other countries with legal cannabis markets around the world.This is the first time a cannabis seed is certified as organic.Calyxtannounced advancements in technology that will make it easier for scientists to bring advanced breeding into hemp. The company, an expert at improving crops like soybeans and wheat to produce more heart-healthy oil or higher fiber, announced its scientists have transformed hemp – an important step as the company can now engineer the hemp genome, unlocking capabilities to selectively breed and deliver improvements in hemp traits through advanced plant breeding like gene editing or even GM level engineering.“We were able to change the plants DNA and regenerate plants through tissue culture, thus accomplishing something that has been fairly elusive in hemp to date,\" said Travis Frey, Ph.D., chief technology officer of Calyxt. “By modernizing the hemp crop, we can now deliver traits that benefits both growers and consumers who are increasingly looking for plant-based and sustainable foods, materials, cosmeceuticals, nutraceuticals and more.\"Zelira Therapeutics Ltd(ASX:ZLD) (OTCQB:ZLDAF) launched its HOPE line of cannabis products in Washington DC. The product line, especially formulated for autism spectrum disorder (ASD) patients of all ages, is also available in Pennsylvania, Louisiana and Australia.“Since we first launched HOPE in the US, our long-term goal has been to make it accessible to ASD patients everywhere, and Washington DC's reciprocity allows us to take a huge step in that direction here in the US,” Dr. Oludare Odumosu, CEO of Zelira Therapeutics, told Benzinga. “The nation's capital is one of the most popular travel destinations, so we are thrilled to be able to offer HOPE there as a treatment option for ASD patients from around the country who travel to DC.”Cannabics Pharmaceuticals Inc.(OTCQB:CNBX), received a “Notice of Allowance” from the Mexican Patent and Trademark Office (IMPI) for a patent on a “System and method for high throughput screening of cancer cells.”Executive MovesCBD products distributor,Khode LLC., announced Tuesday it formed its first board of directors consisting of music artists, executives and CBD industry veterans, including Grammy award-winning artists and entrepreneurDJ Khaled, music executiveLenny S, CEO ofEndexx Corporation(OTC:EDXC)Todd Davis, andStephen HerronandRon CottingofCBD Unlimited, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106689591,"gmtCreate":1620110958413,"gmtModify":1704338814090,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106689591","repostId":"1143573807","repostType":4,"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108381377,"gmtCreate":1620000436699,"gmtModify":1704337064197,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/108381377","repostId":"1135819410","repostType":4,"repost":{"id":"1135819410","pubTimestamp":1619999342,"share":"https://ttm.financial/m/news/1135819410?lang=&edition=fundamental","pubTime":"2021-05-03 07:49","market":"us","language":"en","title":"Uber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1135819410","media":"Barrons","summary":"It’s another packed week of earnings reports, with 130 S&P 500 companies on deck to release their fi","content":"<p>It’s another packed week of earnings reports, with 130 S&amp;P 500 companies on deck to release their first-quarter results. Estée Lauder is among Monday’s highlights, before things pick up on Tuesday:&nbsp;Activision Blizzard, CVS Health, DuPont, Pfizer, and T-Mobile US all report.</p><p>On Wednesday,&nbsp;Barrick Gold, Booking Holdings, General Motors, PayPal Holdings, and Uber Technologies release earnings.&nbsp;Anheuser-Busch InBev, Moderna, Regeneron Pharmaceuticals, Square, and ViacomCBS go on Thursday. And finally, Cigna closes the week on&nbsp;Friday.</p><p><img src=\"https://static.tigerbbs.com/e1a866fbe5118566e68842053d76e2b9\" tg-width=\"1382\" tg-height=\"750\"></p><p>On the economic calendar this week, the&nbsp;main event will jobs Friday.&nbsp;The Bureau of Labor Statistics is forecast to report a gain of 975,000 nonfarm payrolls in April, and an unemployment rate of 5.8%—down from 6% a month earlier.</p><p>Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for April on Monday and its&nbsp;Services equivalent on Wednesday.</p><p>Enterprise Products Partners&nbsp;and Estée Lauder release earnings.</p><p>Merck and&nbsp;Public Storage&nbsp;hold virtual investor days.</p><p><b>The Census Bureau</b>&nbsp;reports construction-spending data for March. Consensus estimate is for a 0.6% month-over-month increase in construction spending to a seasonally adjusted annual rate of $1.53 trillion.</p><p><b>The Institute for Supply</b>&nbsp;Management releases its Manufacturing Purchasing Managers’ Index for April. Economists forecast a 65 reading, roughly even with the March figure. The March reading was the highest for the index since December 1983.</p><p><b>Tuesday 5/4</b></p><p>Activision Blizzard,ConocoPhillips, Cummins, CVS Health,Dominion Energy,DuPont, Eaton, Pfizer,Sysco,and T-Mobile US report quarterly results.</p><p>Eli Lilly&nbsp;holds a conference call to discuss its sustainability initiatives.</p><p>Union Pacific&nbsp;holds its 2021 virtual investor day.</p><p><b>Wednesday 5/5</b></p><p>Barrick Gold, Booking Holdings,BorgWarner,Emerson Electric,General Motors,Hilton Worldwide Holdings,Novo Nordisk,PayPal Holdings, and Uber Technologies release earnings.</p><p><b>ADP releases</b>&nbsp;its National Employment Report for April. Expectations are for a gain of 762,500 jobs in private-sector employment after a 517,000 increase in March.</p><p><b>ISM releases</b>&nbsp;its Services PMI for April. The consensus call is for a 64.6 reading, a tick higher than the March data. The March reading was an all-time high for the index.</p><p><b>Thursday 5/6</b></p><p>Anheuser-Busch InBev,Becton Dickinson,Expedia Group,Fidelity National Information Services,Kellogg, Linde,MetLife,Moderna, Regeneron Pharmaceuticals, Square, ViacomCBS, and&nbsp;Zoetishold conference calls to discuss quarterly results.</p><p><b>The Department of Labor</b>&nbsp;reports initial jobless claims for the week ending on May 1. Initial jobless claims have averaged 611,750 a week in April and are at their lowest level since March of last year.</p><p><b>The Bureau of Labor</b>&nbsp;Statistics reports labor costs and productivity for the first quarter. Expectations are for a seasonally adjusted annual rate of 2.2% productivity growth, compared with a 4.2% decline in the fourth quarter of 2020. Unit labor costs are seen falling 0.4% after rising 6% previously.</p><p><b>Friday 5/7</b></p><p><b>The Bureau of Labor</b>&nbsp;Statistics releases the jobs report for April. Economists forecast a gain of 975,000 in nonfarm payroll employment. The unemployment rate is expected to edge down to 5.8% from 6%.</p><p>Cigna and&nbsp;<b>Liberty Media</b>&nbsp;report earnings.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Uber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-03 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/uber-pfizer-paypal-t-mobile-viacomcbs-general-motors-and-other-stocks-for-investors-to-watch-this-week-51619982000?mod=hp_LEADSUPP_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s another packed week of earnings reports, with 130 S&P 500 companies on deck to release their first-quarter results. Estée Lauder is among Monday’s highlights, before things pick up on Tuesday: ...</p>\n\n<a href=\"https://www.barrons.com/articles/uber-pfizer-paypal-t-mobile-viacomcbs-general-motors-and-other-stocks-for-investors-to-watch-this-week-51619982000?mod=hp_LEADSUPP_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UBER":"优步",".IXIC":"NASDAQ Composite","GM":"通用汽车",".SPX":"S&P 500 Index","PFE":"辉瑞","PYPL":"PayPal",".DJI":"道琼斯","TMUS":"T-Mobile US Inc"},"source_url":"https://www.barrons.com/articles/uber-pfizer-paypal-t-mobile-viacomcbs-general-motors-and-other-stocks-for-investors-to-watch-this-week-51619982000?mod=hp_LEADSUPP_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135819410","content_text":"It’s another packed week of earnings reports, with 130 S&P 500 companies on deck to release their first-quarter results. Estée Lauder is among Monday’s highlights, before things pick up on Tuesday: Activision Blizzard, CVS Health, DuPont, Pfizer, and T-Mobile US all report.On Wednesday, Barrick Gold, Booking Holdings, General Motors, PayPal Holdings, and Uber Technologies release earnings. Anheuser-Busch InBev, Moderna, Regeneron Pharmaceuticals, Square, and ViacomCBS go on Thursday. And finally, Cigna closes the week on Friday.On the economic calendar this week, the main event will jobs Friday. The Bureau of Labor Statistics is forecast to report a gain of 975,000 nonfarm payrolls in April, and an unemployment rate of 5.8%—down from 6% a month earlier.Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for April on Monday and its Services equivalent on Wednesday.Enterprise Products Partners and Estée Lauder release earnings.Merck and Public Storage hold virtual investor days.The Census Bureau reports construction-spending data for March. Consensus estimate is for a 0.6% month-over-month increase in construction spending to a seasonally adjusted annual rate of $1.53 trillion.The Institute for Supply Management releases its Manufacturing Purchasing Managers’ Index for April. Economists forecast a 65 reading, roughly even with the March figure. The March reading was the highest for the index since December 1983.Tuesday 5/4Activision Blizzard,ConocoPhillips, Cummins, CVS Health,Dominion Energy,DuPont, Eaton, Pfizer,Sysco,and T-Mobile US report quarterly results.Eli Lilly holds a conference call to discuss its sustainability initiatives.Union Pacific holds its 2021 virtual investor day.Wednesday 5/5Barrick Gold, Booking Holdings,BorgWarner,Emerson Electric,General Motors,Hilton Worldwide Holdings,Novo Nordisk,PayPal Holdings, and Uber Technologies release earnings.ADP releases its National Employment Report for April. Expectations are for a gain of 762,500 jobs in private-sector employment after a 517,000 increase in March.ISM releases its Services PMI for April. The consensus call is for a 64.6 reading, a tick higher than the March data. The March reading was an all-time high for the index.Thursday 5/6Anheuser-Busch InBev,Becton Dickinson,Expedia Group,Fidelity National Information Services,Kellogg, Linde,MetLife,Moderna, Regeneron Pharmaceuticals, Square, ViacomCBS, and Zoetishold conference calls to discuss quarterly results.The Department of Labor reports initial jobless claims for the week ending on May 1. Initial jobless claims have averaged 611,750 a week in April and are at their lowest level since March of last year.The Bureau of Labor Statistics reports labor costs and productivity for the first quarter. Expectations are for a seasonally adjusted annual rate of 2.2% productivity growth, compared with a 4.2% decline in the fourth quarter of 2020. Unit labor costs are seen falling 0.4% after rising 6% previously.Friday 5/7The Bureau of Labor Statistics releases the jobs report for April. Economists forecast a gain of 975,000 in nonfarm payroll employment. The unemployment rate is expected to edge down to 5.8% from 6%.Cigna and Liberty Media report earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101164349,"gmtCreate":1619863780781,"gmtModify":1704335863821,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/101164349","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&amp;P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.&nbsp; In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson &amp; Johnson</b>&nbsp;can produce up to 3 billion doses for the global market this year. As a reminder, J&amp;J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.  In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1},"isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101165452,"gmtCreate":1619863717376,"gmtModify":1704335863329,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/101165452","repostId":"1142063705","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101165547,"gmtCreate":1619863704989,"gmtModify":1704335863166,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/101165547","repostId":"1142063705","repostType":4,"repost":{"id":"1142063705","pubTimestamp":1619796118,"share":"https://ttm.financial/m/news/1142063705?lang=&edition=fundamental","pubTime":"2021-04-30 23:21","market":"us","language":"en","title":"Europe's antitrust crackdown on Apple hints at what's coming for the company in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=1142063705","media":"CNBC","summary":"For a long time, the European Commission seemed to stand apart from the U.S. in cracking down on tech giants with antitrust fines againstGoogleand privacy rules like the General Data Protection Regulation.“The Commission’s argument onSpotify’sbehalf is the opposite of fair competition,” Apple said in a statement following Vestager’s announcement, referring to the music streaming company that raised the competition complaint. Apple said Spotify wants “all the benefits of the App Store but don’t t","content":"<div>\n<p>For a long time, the European Commission seemed to stand apart from the U.S. in cracking down on tech giants with antitrust fines againstGoogleand privacy rules like the General Data Protection ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/30/eu-leads-tech-crackdown-but-the-us-isnt-far-behind.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe's antitrust crackdown on Apple hints at what's coming for the company in the U.S.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope's antitrust crackdown on Apple hints at what's coming for the company in the U.S.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/30/eu-leads-tech-crackdown-but-the-us-isnt-far-behind.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For a long time, the European Commission seemed to stand apart from the U.S. in cracking down on tech giants with antitrust fines againstGoogleand privacy rules like the General Data Protection ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/30/eu-leads-tech-crackdown-but-the-us-isnt-far-behind.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/04/30/eu-leads-tech-crackdown-but-the-us-isnt-far-behind.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1142063705","content_text":"For a long time, the European Commission seemed to stand apart from the U.S. in cracking down on tech giants with antitrust fines againstGoogleand privacy rules like the General Data Protection Regulation.\nBut when the EU competition policy chief Margrethe Vestagerannounced Friday a preliminary findingthatApplehas abused its dominant power in the distribution of streaming music apps, the U.S. finally seems poised to move in a similar direction.\n“The Commission’s argument onSpotify’sbehalf is the opposite of fair competition,” Apple said in a statement following Vestager’s announcement, referring to the music streaming company that raised the competition complaint. Apple said Spotify wants “all the benefits of the App Store but don’t think they should have to pay anything for that,” by choosing to object to its 15-30% commission on in-app payments for streaming apps.\nApple isn’t currently facing any antitrust charges from government officials in the U.S. and such a lawsuit may never materialize, though the Department of Justice wasreportedly granted oversight of the company’s competitive practices in 2019. But even if the government declines to press charges, recent actions in Congress, state legislatures and in private lawsuits demonstrate a significant shift in the American public’s sentiment toward Apple and the tech industry at large.\nWhen the commissionslapped its first record competition fineagainstGooglein 2017, it wasn’t yet clear that the U.S. might be ready to move on from its once-cozy relationship with its booming tech industry. But in 2018, on the heels of the revelations of howFacebookuser data was used by analytics company Cambridge Analytica during the 2016 election, and increasing questions about how tech platforms can impact American democracy, that seemed to change.\nNow, as Europe continues to move forward with its probe into Apple, the U.S. no longer seems to be so far behind.\nHere’s where Apple stands to face risk of antitrust action or regulation in the U.S.:\nDOJ\nThe DOJ has already moved forward with a massive lawsuit against Google, so it could take some time if it decides to ramp up a probe into Apple. Though the DOJ’s Antitrust Division took on oversight authority of Apple in a 2019 agreement with the FTC, according to aWall Street Journal report, the Google investigation has seemed to take priority.\nStill, then-Attorney General Bill Barr announced later that year that the DOJ wouldconduct a broad antitrust review of Big Tech companies.\nAny action from the DOJ or state enforcers would take the form of a settlement or lawsuit, which would put Apple’s fate in the hands of the courts.\nPrivate lawsuits\nApple’s most immediate challenge in the U.S. has come from private companies bringing antitrust charges against its business in court.\nThe most notable of these lawsuits isfrom Fortnite-maker Epic Games, which is set to begin its trial on Monday. Epic filed its lawsuit with a PR blitz afterchallenging Apple’s in-app payment feeby advertising in its app an alternative, cheaper way to buy character outfits from Epic directly, violating Apple’s rules. That prompted Apple to remove Fortnite from its App Store. Epic filed the suit shortly after and Applefiled counterclaimsagainst Epic for allegedly breaching its contract.\n“Although Epic portrays itself as a modern corporate Robin Hood, in reality it is a multi-billion dollar enterprise that simply wants to pay nothing for the tremendous value it derives from the App Store,” Apple said in a filing with the District Court for the Northern District of California in September.\nCongress\nJust last week,several app-makers testified before the Senate Judiciary subcommittee on antitrust about the alleged anti-competitive harms they’ve facedfrom restrictions on both Apple and Google’s app stores.\nRepresentatives from Apple and Google told lawmakers they simply charge for the technology and the work they put into running the app stores, which have significantly lowered distribution costs for app developers over the years.\nBut witnesses from Tinder-ownerMatch Group, item-tracking device-maker Tile and Spotify painted a different picture.\n“We’re all afraid,” Match Group chief legal officer Jared Sine testified of the platforms’ broad power over their businesses.\nThe witnesses discussed the seemingly arbitrary nature by which Apple allegedly enforces its App Store rules. Spotify’s legal chief claimed Apple has threatened retaliation on numerous occasions and Tile’s top lawyer said Apple denied access to a key feature that wouldimprove their object-tracking product, before utilizing it for Apple’s own rival gadget,called AirTag.\nTile said that while Apple now makes the feature available for third-party developers to incorporate, accessing it would mean handing over a significant amount of data and control to Apple. Apple’s representative said its product is different from Tile’s and opening the feature in question will encourage further competition in the space.\nSenators at the hearing seemed receptive to the app developers’ complaints, which build on earlier claims made before House lawmakers. The House Judiciary subcommittee on antitrust found in a more than year-long probe thatAmazon, Apple, Facebook and Googleall hold monopoly power, and lawmakers are currently crafting bills to enable stronger antitrust enforcement of digital markets.\nState Legislatures\nSeveral state legislatures have beenconsidering bills that would require platforms like Apple and Google to allow app-makers to use their own payment processing systems. While the bills have so far hadvarying degrees of successin the early stages of lawmaking, passage in one state could raise a host of questions about how it should be enforced given the ambiguous nature of digital borders.\nThe bills have been supported by the Coalition for App Fairness, a group of companies that have complained about app store fees, including Epic Games, Match Group and Spotify.\nApple has often argued that it maintains features like payments within its own ecosystem in order to protect consumers and secure their data, though app developers and lawmakers have expressed skepticism about that reasoning.","news_type":1},"isVote":1,"tweetType":1,"viewCount":326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103453961,"gmtCreate":1619806286053,"gmtModify":1704272669486,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/103453961","repostId":"1142063705","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109846141,"gmtCreate":1619685711683,"gmtModify":1704727990284,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Comment pls","listText":"Comment pls","text":"Comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/109846141","repostId":"1183966356","repostType":4,"isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109848106,"gmtCreate":1619685663105,"gmtModify":1704727989154,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109848106","repostId":"1183966356","repostType":4,"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359781660,"gmtCreate":1616423977350,"gmtModify":1704793967675,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/359781660","repostId":"1115438167","repostType":4,"repost":{"id":"1115438167","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1616423750,"share":"https://ttm.financial/m/news/1115438167?lang=&edition=fundamental","pubTime":"2021-03-22 22:35","market":"us","language":"en","title":"Some “meme” stocks are slipping","url":"https://stock-news.laohu8.com/highlight/detail?id=1115438167","media":"Tiger Newspress","summary":"Some “meme” stocks are slipping in Monday trading,AMC Entertainment stock fall 13%,the shares of Sundial Growers drop 7%,GameStop Corp. stock is down 2%.These stocks are identified as a potential gamble using methodology from recently published research paper—from Alok Kumar of the University of Miami, Houng Nguyen of the University of Danang, and Talis Putnins at the University of Technology Sydney and Stockholm School of Economics. The group proposed looking at the average volume over 30 days ","content":"<p>Some&nbsp;“meme”&nbsp;stocks&nbsp;are&nbsp;slipping&nbsp;in&nbsp;Monday&nbsp;trading,AMC&nbsp;Entertainment&nbsp;stock&nbsp;fall&nbsp;13%,the&nbsp;shares&nbsp;of&nbsp;Sundial&nbsp;Growers&nbsp;drop&nbsp;7%,GameStop&nbsp;Corp.&nbsp;stock&nbsp;is&nbsp;down&nbsp;2%.</p><p>These stocks are identified as a potential gamble using methodology from recently published research paper—from Alok Kumar of the University of Miami, Houng Nguyen of the University of Danang, and Talis Putnins at the University of Technology Sydney and Stockholm School of Economics. The group proposed looking at the average volume over 30 days compared to market cap as a way of determining what they called lottery stocks.</p><p><img src=\"https://static.tigerbbs.com/de78ffef1bc7540f75fca0332d31e69c\" tg-width=\"371\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some “meme” stocks are slipping</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome “meme” stocks are slipping\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-22 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some&nbsp;“meme”&nbsp;stocks&nbsp;are&nbsp;slipping&nbsp;in&nbsp;Monday&nbsp;trading,AMC&nbsp;Entertainment&nbsp;stock&nbsp;fall&nbsp;13%,the&nbsp;shares&nbsp;of&nbsp;Sundial&nbsp;Growers&nbsp;drop&nbsp;7%,GameStop&nbsp;Corp.&nbsp;stock&nbsp;is&nbsp;down&nbsp;2%.</p><p>These stocks are identified as a potential gamble using methodology from recently published research paper—from Alok Kumar of the University of Miami, Houng Nguyen of the University of Danang, and Talis Putnins at the University of Technology Sydney and Stockholm School of Economics. The group proposed looking at the average volume over 30 days compared to market cap as a way of determining what they called lottery stocks.</p><p><img src=\"https://static.tigerbbs.com/de78ffef1bc7540f75fca0332d31e69c\" tg-width=\"371\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站","SNDL":"SNDL Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115438167","content_text":"Some “meme” stocks are slipping in Monday trading,AMC Entertainment stock fall 13%,the shares of Sundial Growers drop 7%,GameStop Corp. stock is down 2%.These stocks are identified as a potential gamble using methodology from recently published research paper—from Alok Kumar of the University of Miami, Houng Nguyen of the University of Danang, and Talis Putnins at the University of Technology Sydney and Stockholm School of Economics. The group proposed looking at the average volume over 30 days compared to market cap as a way of determining what they called lottery stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359983001,"gmtCreate":1616320181403,"gmtModify":1704792886901,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/359983001","repostId":"1117450855","repostType":4,"isVote":1,"tweetType":1,"viewCount":217,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359989749,"gmtCreate":1616320115481,"gmtModify":1704792886409,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/359989749","repostId":"1126157111","repostType":4,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":103453961,"gmtCreate":1619806286053,"gmtModify":1704272669486,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/103453961","repostId":"1142063705","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108381377,"gmtCreate":1620000436699,"gmtModify":1704337064197,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/108381377","repostId":"1135819410","repostType":4,"repost":{"id":"1135819410","pubTimestamp":1619999342,"share":"https://ttm.financial/m/news/1135819410?lang=&edition=fundamental","pubTime":"2021-05-03 07:49","market":"us","language":"en","title":"Uber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1135819410","media":"Barrons","summary":"It’s another packed week of earnings reports, with 130 S&P 500 companies on deck to release their fi","content":"<p>It’s another packed week of earnings reports, with 130 S&amp;P 500 companies on deck to release their first-quarter results. Estée Lauder is among Monday’s highlights, before things pick up on Tuesday:&nbsp;Activision Blizzard, CVS Health, DuPont, Pfizer, and T-Mobile US all report.</p><p>On Wednesday,&nbsp;Barrick Gold, Booking Holdings, General Motors, PayPal Holdings, and Uber Technologies release earnings.&nbsp;Anheuser-Busch InBev, Moderna, Regeneron Pharmaceuticals, Square, and ViacomCBS go on Thursday. And finally, Cigna closes the week on&nbsp;Friday.</p><p><img src=\"https://static.tigerbbs.com/e1a866fbe5118566e68842053d76e2b9\" tg-width=\"1382\" tg-height=\"750\"></p><p>On the economic calendar this week, the&nbsp;main event will jobs Friday.&nbsp;The Bureau of Labor Statistics is forecast to report a gain of 975,000 nonfarm payrolls in April, and an unemployment rate of 5.8%—down from 6% a month earlier.</p><p>Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for April on Monday and its&nbsp;Services equivalent on Wednesday.</p><p>Enterprise Products Partners&nbsp;and Estée Lauder release earnings.</p><p>Merck and&nbsp;Public Storage&nbsp;hold virtual investor days.</p><p><b>The Census Bureau</b>&nbsp;reports construction-spending data for March. Consensus estimate is for a 0.6% month-over-month increase in construction spending to a seasonally adjusted annual rate of $1.53 trillion.</p><p><b>The Institute for Supply</b>&nbsp;Management releases its Manufacturing Purchasing Managers’ Index for April. Economists forecast a 65 reading, roughly even with the March figure. The March reading was the highest for the index since December 1983.</p><p><b>Tuesday 5/4</b></p><p>Activision Blizzard,ConocoPhillips, Cummins, CVS Health,Dominion Energy,DuPont, Eaton, Pfizer,Sysco,and T-Mobile US report quarterly results.</p><p>Eli Lilly&nbsp;holds a conference call to discuss its sustainability initiatives.</p><p>Union Pacific&nbsp;holds its 2021 virtual investor day.</p><p><b>Wednesday 5/5</b></p><p>Barrick Gold, Booking Holdings,BorgWarner,Emerson Electric,General Motors,Hilton Worldwide Holdings,Novo Nordisk,PayPal Holdings, and Uber Technologies release earnings.</p><p><b>ADP releases</b>&nbsp;its National Employment Report for April. Expectations are for a gain of 762,500 jobs in private-sector employment after a 517,000 increase in March.</p><p><b>ISM releases</b>&nbsp;its Services PMI for April. The consensus call is for a 64.6 reading, a tick higher than the March data. The March reading was an all-time high for the index.</p><p><b>Thursday 5/6</b></p><p>Anheuser-Busch InBev,Becton Dickinson,Expedia Group,Fidelity National Information Services,Kellogg, Linde,MetLife,Moderna, Regeneron Pharmaceuticals, Square, ViacomCBS, and&nbsp;Zoetishold conference calls to discuss quarterly results.</p><p><b>The Department of Labor</b>&nbsp;reports initial jobless claims for the week ending on May 1. Initial jobless claims have averaged 611,750 a week in April and are at their lowest level since March of last year.</p><p><b>The Bureau of Labor</b>&nbsp;Statistics reports labor costs and productivity for the first quarter. Expectations are for a seasonally adjusted annual rate of 2.2% productivity growth, compared with a 4.2% decline in the fourth quarter of 2020. Unit labor costs are seen falling 0.4% after rising 6% previously.</p><p><b>Friday 5/7</b></p><p><b>The Bureau of Labor</b>&nbsp;Statistics releases the jobs report for April. Economists forecast a gain of 975,000 in nonfarm payroll employment. The unemployment rate is expected to edge down to 5.8% from 6%.</p><p>Cigna and&nbsp;<b>Liberty Media</b>&nbsp;report earnings.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Uber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUber, Pfizer, PayPal, T-Mobile, ViacomCBS, General Motors, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-03 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/uber-pfizer-paypal-t-mobile-viacomcbs-general-motors-and-other-stocks-for-investors-to-watch-this-week-51619982000?mod=hp_LEADSUPP_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s another packed week of earnings reports, with 130 S&P 500 companies on deck to release their first-quarter results. Estée Lauder is among Monday’s highlights, before things pick up on Tuesday: ...</p>\n\n<a href=\"https://www.barrons.com/articles/uber-pfizer-paypal-t-mobile-viacomcbs-general-motors-and-other-stocks-for-investors-to-watch-this-week-51619982000?mod=hp_LEADSUPP_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UBER":"优步",".IXIC":"NASDAQ Composite","GM":"通用汽车",".SPX":"S&P 500 Index","PFE":"辉瑞","PYPL":"PayPal",".DJI":"道琼斯","TMUS":"T-Mobile US Inc"},"source_url":"https://www.barrons.com/articles/uber-pfizer-paypal-t-mobile-viacomcbs-general-motors-and-other-stocks-for-investors-to-watch-this-week-51619982000?mod=hp_LEADSUPP_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135819410","content_text":"It’s another packed week of earnings reports, with 130 S&P 500 companies on deck to release their first-quarter results. Estée Lauder is among Monday’s highlights, before things pick up on Tuesday: Activision Blizzard, CVS Health, DuPont, Pfizer, and T-Mobile US all report.On Wednesday, Barrick Gold, Booking Holdings, General Motors, PayPal Holdings, and Uber Technologies release earnings. Anheuser-Busch InBev, Moderna, Regeneron Pharmaceuticals, Square, and ViacomCBS go on Thursday. And finally, Cigna closes the week on Friday.On the economic calendar this week, the main event will jobs Friday. The Bureau of Labor Statistics is forecast to report a gain of 975,000 nonfarm payrolls in April, and an unemployment rate of 5.8%—down from 6% a month earlier.Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for April on Monday and its Services equivalent on Wednesday.Enterprise Products Partners and Estée Lauder release earnings.Merck and Public Storage hold virtual investor days.The Census Bureau reports construction-spending data for March. Consensus estimate is for a 0.6% month-over-month increase in construction spending to a seasonally adjusted annual rate of $1.53 trillion.The Institute for Supply Management releases its Manufacturing Purchasing Managers’ Index for April. Economists forecast a 65 reading, roughly even with the March figure. The March reading was the highest for the index since December 1983.Tuesday 5/4Activision Blizzard,ConocoPhillips, Cummins, CVS Health,Dominion Energy,DuPont, Eaton, Pfizer,Sysco,and T-Mobile US report quarterly results.Eli Lilly holds a conference call to discuss its sustainability initiatives.Union Pacific holds its 2021 virtual investor day.Wednesday 5/5Barrick Gold, Booking Holdings,BorgWarner,Emerson Electric,General Motors,Hilton Worldwide Holdings,Novo Nordisk,PayPal Holdings, and Uber Technologies release earnings.ADP releases its National Employment Report for April. Expectations are for a gain of 762,500 jobs in private-sector employment after a 517,000 increase in March.ISM releases its Services PMI for April. The consensus call is for a 64.6 reading, a tick higher than the March data. The March reading was an all-time high for the index.Thursday 5/6Anheuser-Busch InBev,Becton Dickinson,Expedia Group,Fidelity National Information Services,Kellogg, Linde,MetLife,Moderna, Regeneron Pharmaceuticals, Square, ViacomCBS, and Zoetishold conference calls to discuss quarterly results.The Department of Labor reports initial jobless claims for the week ending on May 1. Initial jobless claims have averaged 611,750 a week in April and are at their lowest level since March of last year.The Bureau of Labor Statistics reports labor costs and productivity for the first quarter. Expectations are for a seasonally adjusted annual rate of 2.2% productivity growth, compared with a 4.2% decline in the fourth quarter of 2020. Unit labor costs are seen falling 0.4% after rising 6% previously.Friday 5/7The Bureau of Labor Statistics releases the jobs report for April. Economists forecast a gain of 975,000 in nonfarm payroll employment. The unemployment rate is expected to edge down to 5.8% from 6%.Cigna and Liberty Media report earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109846141,"gmtCreate":1619685711683,"gmtModify":1704727990284,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Comment pls","listText":"Comment pls","text":"Comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/109846141","repostId":"1183966356","repostType":4,"repost":{"id":"1183966356","pubTimestamp":1619665696,"share":"https://ttm.financial/m/news/1183966356?lang=&edition=fundamental","pubTime":"2021-04-29 11:08","market":"us","language":"en","title":"NIO Q1 2021 Earnings Report Preview: What to Look For","url":"https://stock-news.laohu8.com/highlight/detail?id=1183966356","media":"InvestoPedia","summary":"Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.Revenue is expected to soar on expanding vehicle sales.NIO Inc. , like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles . NIO's production stoppage in late March had little impact on the company's record ve","content":"<p>Focus on NIO vehicle deliveries</p>\n<p><b>KEY TAKEAWAYS</b></p>\n<ul>\n <li>Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.</li>\n <li>Vehicle deliveries, already announced, rose dramatically YOY.</li>\n <li>Revenue is expected to soar on expanding vehicle sales.</li>\n</ul>\n<p>NIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.</p>\n<p>Investors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.</p>\n<p>Vehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.</p>\n<p>Shares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&amp;P 500's total return of 45.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a11e1a915810ccbc7f07ec2adf16865b\" tg-width=\"3004\" tg-height=\"1798\"><span>Source: TradingView.</span></p>\n<p><b>NIO Earnings History</b></p>\n<p>The stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's&nbsp;Q4 FY 2020 earnings&nbsp;report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its&nbsp;gross margin&nbsp;rose to 17.2% compared to negative 8.9% in the year-ago quarter.</p>\n<p>In Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.</p>\n<p>Analysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d412a9c0aea28621f713f5afbfba444c\" tg-width=\"885\" tg-height=\"352\"><span>Source: Visible Alpha; NIO Inc.</span></p>\n<p><b>The Key Metric</b></p>\n<p>As mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.</p>\n<p>NIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.</p>","source":"lsy1606203311635","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Q1 2021 Earnings Report Preview: What to Look For</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Q1 2021 Earnings Report Preview: What to Look For\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-29 11:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991><strong>InvestoPedia</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Focus on NIO vehicle deliveries\nKEY TAKEAWAYS\n\nAnalysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.\nVehicle deliveries, already announced, rose dramatically YOY.\nRevenue is ...</p>\n\n<a href=\"https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183966356","content_text":"Focus on NIO vehicle deliveries\nKEY TAKEAWAYS\n\nAnalysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.\nVehicle deliveries, already announced, rose dramatically YOY.\nRevenue is expected to soar on expanding vehicle sales.\n\nNIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.\nInvestors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.\nVehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.\nShares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&P 500's total return of 45.5%.\nSource: TradingView.\nNIO Earnings History\nThe stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's Q4 FY 2020 earnings report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its gross margin rose to 17.2% compared to negative 8.9% in the year-ago quarter.\nIn Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.\nAnalysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.\nSource: Visible Alpha; NIO Inc.\nThe Key Metric\nAs mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.\nNIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359989749,"gmtCreate":1616320115481,"gmtModify":1704792886409,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/359989749","repostId":"1126157111","repostType":4,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":198304850,"gmtCreate":1620922683970,"gmtModify":1704350606417,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/198304850","repostId":"1116555518","repostType":4,"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101164349,"gmtCreate":1619863780781,"gmtModify":1704335863821,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/101164349","repostId":"1165708828","repostType":4,"isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139371184,"gmtCreate":1621596540548,"gmtModify":1704360276407,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/139371184","repostId":"1196025603","repostType":4,"repost":{"id":"1196025603","pubTimestamp":1621593525,"share":"https://ttm.financial/m/news/1196025603?lang=&edition=fundamental","pubTime":"2021-05-21 18:38","market":"us","language":"en","title":"Ocugen Faces Long Odds Before Gaining From Its Covid-19 Support Role","url":"https://stock-news.laohu8.com/highlight/detail?id=1196025603","media":"InvestorPlace","summary":"OCGN stock faces some tough vaccine math in its home country.\n\nWhileOcugen(NASDAQ:OCGN) stock is up ","content":"<blockquote>\n <b>OCGN stock faces some tough vaccine math in its home country.</b>\n</blockquote>\n<p>While<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) stock is up over 200% this year, ithasn’tbeen a case of slow and steady growth. On two separate occasions, the shares have been much higher. Yet when I wrote about OCGN stocka month ago, the stock was about 40% below its current price.</p>\n<p><img src=\"https://static.tigerbbs.com/160226899c7a4d832ba23044479cfb70\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: Shutterstock</p>\n<p>Volatility like that&nbsp;merits some explanation. The first time OCGN stock popped, in mid-February waslikely dueto the meme stock craze. But when the stock spiked in April, it was due to a more fundamental reason.Ocugenhad become a recognized player in the Covid-19 vaccine rollout.</p>\n<p>That would be more intriguing ifOcugenwas developing its own vaccine. Not that it would make it any less of a long shot, but right now the company is serving the role of a middleman. And it could wind up getting cut out entirely.</p>\n<p><b>AmericaDoesn’t&nbsp;NeedCovaxin</b></p>\n<p>As I noted last month,Ocugenis in a partnershipwith India’s<b>Bharat Biotech</b>regarding&nbsp;the latter company’s Covid-19 vaccine,Covaxin. Specifically,Ocugen&nbsp;will get 45% of the profits from the sale ofCovaxinin the United States.</p>\n<p>The concern I had then is the same concern I have now. The U.S. does notrequire&nbsp;another Covid-19 vaccine. And, althoughCovaxinhas received an emergency use authorization in India, it continues toundergo Phase 3 trials.</p>\n<p>Under terms of the agreement,Ocugen&nbsp;willbe responsible for&nbsp;the vaccine’s clinical development, regulatory approval (which includes its EUA) and commercialization in the U.S.</p>\n<p>And as my<i>InvestorPlace</i>&nbsp;colleague Larry Ramer points out,&nbsp;thatapproval appears unlikely.&nbsp;Ramer recentlyobserved&nbsp;that the FDA’s written protocols state that to grant an EUA it “should carry out visits to the sites at which Phase 3 trials are being carried out.”</p>\n<p>That would mean the FDA would have to go to India which is currently under a travel ban by the U.S.</p>\n<p><b>Not Part of the Arsenal</b></p>\n<p>One of the recent bullish arguments for OCGN stock is that the company willbenefit&nbsp;fromIndia’s pause on exportingCovaxin. India will not export the vaccine until at least October to stem the ongoing surge in that country. The rationale is thatOcugenwill benefit as more vaccines will need to be created and exported.</p>\n<p>But again,I’m&nbsp;skeptical. First, asI’vepointed out, the United States is not a nation that needs to import vaccines. In fact, President Biden is pledging that the U.S. will be anarsenal for global distribution&nbsp;of Covid-19 vaccines. OnMay 17,2021&nbsp;the president announced that the U.S. would share anadditional&nbsp;20 million doses of the vaccine. This was in addition to the 60 million doses that have already been exported.</p>\n<p>This brings me to a second point. Currently,Covaxinis not part of that arsenal. And even if it were,it’sunclear how exporting Covaxin would work withOcugen’s&nbsp;agreement in which the company receives compensation for sales ofCovaxin<i>within the United States</i>(emphasis mine).</p>\n<p><b>There Are Better Options Than OCGN Stock</b></p>\n<p>Ocugen&nbsp;specializes in treating rare eye diseases. Theydon’tcurrently have a product in market. But one of their candidates,INO-4000, is beginning the clinical trial stage.&nbsp;The partnership withBahrat&nbsp;Biotech may be successful in raising some non-dilutive revenue. But for reasonsI’venoted in this article, that should not be seen as a given.</p>\n<p>There are other small-cap biotech companies that may have better odds of bringing anadditionalCovid-19 vaccine to market. I would suggest&nbsp;<b>Inovio Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>INO</u></b>) or&nbsp;<b>iBio</b>(NYSEAMERICAN:<b><u>IBIO</u></b>). These companies also face long odds.Howeverboth areat least manufacturing their own vaccine. And both companies are bringing something innovative to the table.</p>\n<p>I’massuming Ocugen’s motives for trying toassistin the Covid-19 vaccine race are pure. I imagine all biotech companies want to alleviate suffering and needless death from this virus. But the company is facing longer odds to achieve that goal thanI believe short-term tradersare considering.</p>\n<p><i>On the date of publication, ChrisMarkochdid not have (either directly or indirectly) any positions in the securities mentioned in this article.The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com</i>Publishing Guidelines<i>.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen Faces Long Odds Before Gaining From Its Covid-19 Support Role</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen Faces Long Odds Before Gaining From Its Covid-19 Support Role\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-21 18:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/ocgn-stock-faces-long-odds-in-covid-support-role/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OCGN stock faces some tough vaccine math in its home country.\n\nWhileOcugen(NASDAQ:OCGN) stock is up over 200% this year, ithasn’tbeen a case of slow and steady growth. On two separate occasions, the ...</p>\n\n<a href=\"https://investorplace.com/2021/05/ocgn-stock-faces-long-odds-in-covid-support-role/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/05/ocgn-stock-faces-long-odds-in-covid-support-role/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196025603","content_text":"OCGN stock faces some tough vaccine math in its home country.\n\nWhileOcugen(NASDAQ:OCGN) stock is up over 200% this year, ithasn’tbeen a case of slow and steady growth. On two separate occasions, the shares have been much higher. Yet when I wrote about OCGN stocka month ago, the stock was about 40% below its current price.\nSource: Shutterstock\nVolatility like that merits some explanation. The first time OCGN stock popped, in mid-February waslikely dueto the meme stock craze. But when the stock spiked in April, it was due to a more fundamental reason.Ocugenhad become a recognized player in the Covid-19 vaccine rollout.\nThat would be more intriguing ifOcugenwas developing its own vaccine. Not that it would make it any less of a long shot, but right now the company is serving the role of a middleman. And it could wind up getting cut out entirely.\nAmericaDoesn’t NeedCovaxin\nAs I noted last month,Ocugenis in a partnershipwith India’sBharat Biotechregarding the latter company’s Covid-19 vaccine,Covaxin. Specifically,Ocugen will get 45% of the profits from the sale ofCovaxinin the United States.\nThe concern I had then is the same concern I have now. The U.S. does notrequire another Covid-19 vaccine. And, althoughCovaxinhas received an emergency use authorization in India, it continues toundergo Phase 3 trials.\nUnder terms of the agreement,Ocugen willbe responsible for the vaccine’s clinical development, regulatory approval (which includes its EUA) and commercialization in the U.S.\nAnd as myInvestorPlace colleague Larry Ramer points out, thatapproval appears unlikely. Ramer recentlyobserved that the FDA’s written protocols state that to grant an EUA it “should carry out visits to the sites at which Phase 3 trials are being carried out.”\nThat would mean the FDA would have to go to India which is currently under a travel ban by the U.S.\nNot Part of the Arsenal\nOne of the recent bullish arguments for OCGN stock is that the company willbenefit fromIndia’s pause on exportingCovaxin. India will not export the vaccine until at least October to stem the ongoing surge in that country. The rationale is thatOcugenwill benefit as more vaccines will need to be created and exported.\nBut again,I’m skeptical. First, asI’vepointed out, the United States is not a nation that needs to import vaccines. In fact, President Biden is pledging that the U.S. will be anarsenal for global distribution of Covid-19 vaccines. OnMay 17,2021 the president announced that the U.S. would share anadditional 20 million doses of the vaccine. This was in addition to the 60 million doses that have already been exported.\nThis brings me to a second point. Currently,Covaxinis not part of that arsenal. And even if it were,it’sunclear how exporting Covaxin would work withOcugen’s agreement in which the company receives compensation for sales ofCovaxinwithin the United States(emphasis mine).\nThere Are Better Options Than OCGN Stock\nOcugen specializes in treating rare eye diseases. Theydon’tcurrently have a product in market. But one of their candidates,INO-4000, is beginning the clinical trial stage. The partnership withBahrat Biotech may be successful in raising some non-dilutive revenue. But for reasonsI’venoted in this article, that should not be seen as a given.\nThere are other small-cap biotech companies that may have better odds of bringing anadditionalCovid-19 vaccine to market. I would suggest Inovio Pharmaceuticals (NASDAQ:INO) or iBio(NYSEAMERICAN:IBIO). These companies also face long odds.Howeverboth areat least manufacturing their own vaccine. And both companies are bringing something innovative to the table.\nI’massuming Ocugen’s motives for trying toassistin the Covid-19 vaccine race are pure. I imagine all biotech companies want to alleviate suffering and needless death from this virus. But the company is facing longer odds to achieve that goal thanI believe short-term tradersare considering.\nOn the date of publication, ChrisMarkochdid not have (either directly or indirectly) any positions in the securities mentioned in this article.The opinions expressed in this article are those of the writer, subject to the InvestorPlace.comPublishing Guidelines.","news_type":1},"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190950426,"gmtCreate":1620573862065,"gmtModify":1704345091309,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190950426","repostId":"1170905579","repostType":4,"repost":{"id":"1170905579","pubTimestamp":1620462497,"share":"https://ttm.financial/m/news/1170905579?lang=&edition=fundamental","pubTime":"2021-05-08 16:28","market":"us","language":"en","title":"The real story of the Trump-Facebook saga","url":"https://stock-news.laohu8.com/highlight/detail?id=1170905579","media":"Yahoo Finance ","summary":"It’s not this complicated.Like other bumbling corporations reluctant to take a stand, Facebook and i","content":"<p>It’s not this complicated.</p><p>Like other bumbling corporations reluctant to take a stand, Facebook and its CEO, Mark Zuckerberg, have turned a temporary controversy into an ongoing fiasco. The social-media giant could have permanently banned then-President Donald Trump on Jan. 7, after he used the platform to lie about the 2020 election and praise rioters trying to seize control of the US Capitol the day before. Trump and his supporters would have squealed, but decisive action by Facebook would have left them no choice: Deal with it.</p><p>Instead, Facebook (FB) suspended Trump’s account “indefinitely,” while asking the company’s “oversight board”—a group of outside policy experts—to recommend a permanent solution. On May 5, the board “upheld” Facebook’s decision to exile Trump, but it alsodinged Facebook for the arbitrary application of vague standards. Instead of handing the company a simple answer, it told Facebook to come up with a permanent solution of its own within six months.</p><p>Have you ever watched an overwrought parent try to negotiate with a misbehaving five-year-old? Instead of telling the kid to stop being a brat, the parent tries to persuade the child why it’s important to stop being a brat, hoping the child will stop being a brat because he sees the light and learns an important life lesson in the process. You want to shout, “just tell him to stop it!”</p><p>This is what’s going on with Facebook and its oversight board. Facebook is trying to dodge responsibility for making a decision sure to be unpopular with some of its users. The oversight board, relishing its own perceived importance, issued an11,800 word communiquethat didn’t resolve anything. The real answer is painfully obvious: Facebook should permanently ban anybody who’s a chronic liar and violence inciter. Yet nobody in Faceworld can say it.</p><p>Let’s quickly review what’s really happening in the Facebook saga, by annotating the motives of the key players. It won’t take thousands of words.</p><p><b>Donald Trump.</b>He wants the largest possible audience for his propaganda, includinghis lies about the 2020 election being stolenfrom him. Trump is a wannabe despot whoclaims persecutionto distract followers from his aberrant behavior and his election losses. It also helps him raise money from gullible sympathizers. As a private-sector entity, Facebook has the right to boot users who cause the company trouble, which Trump clearly did. There’s no free speech or First Amendment issue at all, because Trump is still free to publish his own views on a platform of his own. If it were a free speech issue, Facebook could cite the First Amendment to declare it faces no obligation to publish anybody's views, just as a newspaper doesn't have to run government manifestoes. Trump's claim of “censorship” is ridiculous, but it obviously keeps him in the news and fires up his supporters.</p><p><b>The Trump cult.</b>Echoing Trump,other Republican politiciansclaim Facebook and other social-media sites single out conservatives for “censorship.” They’re mixing up cause and effect. Election lies and other disinformation are now a staple of the Trump wing of the Republican party, and these lies trigger retaliation by the companies hosting the offending accounts. If Trumpers lied less, social media would “censor” them less. Most of them know this, but “censorship” gives them a bogus cause that helps generate outrage among their followers and juice their own campaign contributions.</p><p><b>Mark Zuckerberg.</b>The Facebook CEO cares about making money above all, and there’s not necessarily anything wrong with that. Zuckerberg wants to outsource the decision about Trump so that he and the company don’t seem to be directly responsible for an outcome likely to anger millions of conservative Facebook users. He may also want to have plausible deniability the next time he testifies before Congress, so that when a Trump lackey such as Rep. Jim Jordan (R., Ohio) tries to pillory Zuckerberg for persecuting Trump, Zuckerberg can say, “it wasn’t me.” It’s not clear Facebook is actually losing money because of the Trump feud, but even if it is, Zuckerberg has miscalculated by failing to account for other damage caused by allowing the Trump debacle to fester.</p><p><b>Democrats.</b>They don’t like Facebook either, but Sen. Elizabeth Warren and other Facebook critics on the left have a different gripe:Facebook abuses user dataand hastoo much powerin the digital advertising market. Facebook has few friends in Congress, but it does have one important thing going for it: The company’s Republican and Democratic critics are so divided that they may never agree on any legislation that reins in the company’s power.</p><p>There’s only one way the Facebook-Trump saga can end: A permanent Trump ban. Trump will never stop lying, and any negotiated return to Facebook would only restart the cycle. Around the same time Facebook indefinitely banned Trump, Twitteraxed his account permanently. It didn’t drag out the decision or ask somebody else to decide for it. Twitter (TWTR) is no longer explaining or relitigating its Trump decision, which is where Facebook might be in a year or two. It has already taken too long.</p>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The real story of the Trump-Facebook saga</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe real story of the Trump-Facebook saga\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 16:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/the-real-story-of-the-trump-facebook-saga-145941882.html><strong>Yahoo Finance </strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s not this complicated.Like other bumbling corporations reluctant to take a stand, Facebook and its CEO, Mark Zuckerberg, have turned a temporary controversy into an ongoing fiasco. The social-...</p>\n\n<a href=\"https://finance.yahoo.com/news/the-real-story-of-the-trump-facebook-saga-145941882.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/the-real-story-of-the-trump-facebook-saga-145941882.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170905579","content_text":"It’s not this complicated.Like other bumbling corporations reluctant to take a stand, Facebook and its CEO, Mark Zuckerberg, have turned a temporary controversy into an ongoing fiasco. The social-media giant could have permanently banned then-President Donald Trump on Jan. 7, after he used the platform to lie about the 2020 election and praise rioters trying to seize control of the US Capitol the day before. Trump and his supporters would have squealed, but decisive action by Facebook would have left them no choice: Deal with it.Instead, Facebook (FB) suspended Trump’s account “indefinitely,” while asking the company’s “oversight board”—a group of outside policy experts—to recommend a permanent solution. On May 5, the board “upheld” Facebook’s decision to exile Trump, but it alsodinged Facebook for the arbitrary application of vague standards. Instead of handing the company a simple answer, it told Facebook to come up with a permanent solution of its own within six months.Have you ever watched an overwrought parent try to negotiate with a misbehaving five-year-old? Instead of telling the kid to stop being a brat, the parent tries to persuade the child why it’s important to stop being a brat, hoping the child will stop being a brat because he sees the light and learns an important life lesson in the process. You want to shout, “just tell him to stop it!”This is what’s going on with Facebook and its oversight board. Facebook is trying to dodge responsibility for making a decision sure to be unpopular with some of its users. The oversight board, relishing its own perceived importance, issued an11,800 word communiquethat didn’t resolve anything. The real answer is painfully obvious: Facebook should permanently ban anybody who’s a chronic liar and violence inciter. Yet nobody in Faceworld can say it.Let’s quickly review what’s really happening in the Facebook saga, by annotating the motives of the key players. It won’t take thousands of words.Donald Trump.He wants the largest possible audience for his propaganda, includinghis lies about the 2020 election being stolenfrom him. Trump is a wannabe despot whoclaims persecutionto distract followers from his aberrant behavior and his election losses. It also helps him raise money from gullible sympathizers. As a private-sector entity, Facebook has the right to boot users who cause the company trouble, which Trump clearly did. There’s no free speech or First Amendment issue at all, because Trump is still free to publish his own views on a platform of his own. If it were a free speech issue, Facebook could cite the First Amendment to declare it faces no obligation to publish anybody's views, just as a newspaper doesn't have to run government manifestoes. Trump's claim of “censorship” is ridiculous, but it obviously keeps him in the news and fires up his supporters.The Trump cult.Echoing Trump,other Republican politiciansclaim Facebook and other social-media sites single out conservatives for “censorship.” They’re mixing up cause and effect. Election lies and other disinformation are now a staple of the Trump wing of the Republican party, and these lies trigger retaliation by the companies hosting the offending accounts. If Trumpers lied less, social media would “censor” them less. Most of them know this, but “censorship” gives them a bogus cause that helps generate outrage among their followers and juice their own campaign contributions.Mark Zuckerberg.The Facebook CEO cares about making money above all, and there’s not necessarily anything wrong with that. Zuckerberg wants to outsource the decision about Trump so that he and the company don’t seem to be directly responsible for an outcome likely to anger millions of conservative Facebook users. He may also want to have plausible deniability the next time he testifies before Congress, so that when a Trump lackey such as Rep. Jim Jordan (R., Ohio) tries to pillory Zuckerberg for persecuting Trump, Zuckerberg can say, “it wasn’t me.” It’s not clear Facebook is actually losing money because of the Trump feud, but even if it is, Zuckerberg has miscalculated by failing to account for other damage caused by allowing the Trump debacle to fester.Democrats.They don’t like Facebook either, but Sen. Elizabeth Warren and other Facebook critics on the left have a different gripe:Facebook abuses user dataand hastoo much powerin the digital advertising market. Facebook has few friends in Congress, but it does have one important thing going for it: The company’s Republican and Democratic critics are so divided that they may never agree on any legislation that reins in the company’s power.There’s only one way the Facebook-Trump saga can end: A permanent Trump ban. Trump will never stop lying, and any negotiated return to Facebook would only restart the cycle. Around the same time Facebook indefinitely banned Trump, Twitteraxed his account permanently. It didn’t drag out the decision or ask somebody else to decide for it. Twitter (TWTR) is no longer explaining or relitigating its Trump decision, which is where Facebook might be in a year or two. It has already taken too long.","news_type":1},"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190950664,"gmtCreate":1620573837358,"gmtModify":1704345091792,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190950664","repostId":"1147179681","repostType":4,"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106689591,"gmtCreate":1620110958413,"gmtModify":1704338814090,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106689591","repostId":"1143573807","repostType":4,"repost":{"id":"1143573807","pubTimestamp":1620108729,"share":"https://ttm.financial/m/news/1143573807?lang=&edition=fundamental","pubTime":"2021-05-04 14:12","market":"us","language":"en","title":"J.P. Morgan's short-term look finds picks, pans in telecom/pay TV","url":"https://stock-news.laohu8.com/highlight/detail?id=1143573807","media":"seeking alpha","summary":"J.P. Morgan's \"Spectrum of Opportunity\" note offers a chance to re-rank telecom and pay television s","content":"<ul><li>J.P. Morgan's \"Spectrum of Opportunity\" note offers a chance to re-rank telecom and pay television stocks for May performance -updating its longer-term ratings with the prospect of benefiting from shorter-term catalysts (including such things as seasonality).</li><li>And turning to its top picks for May yields several names worthy of some catalyst-based attention (based on a points system it assigns to sort out how to weigh alternatives).</li><li>One is Comcast(NASDAQ:CMCSA), which is likely to keep seeing strong cable trends along with re-opening data points for its parks and film operations. It likes the stock long-term relative to megacap peers AT&amp;T(NYSE:T)and Verizon(NYSE:VZ)\"due to strong fundamentals at cable and an improving backdrop at NBC/Sky.\" The broader market is concerned about growing broadband competition, but Comcast's trends are staying strong driven by acquisition and churn as it grows share.</li><li>Meanwhile, theme park demand is ramping, with open parks breaking even during the first quarter, and there's upside to NBC/consolidated EBITDA for 2021. It has a $62 price target.</li><li>On a slightly different time frame is T-Mobile (TMUS; reporting after the close tomorrow): It's the firm's best long-term idea (based on substantial operating efficiencies and cash flow growth for coming years), and while it's not looking for a big Q1 beat, it's still a short-term pick.</li><li>\"After a strong quarter by AT&amp;T but soft one from Verizon on postpaid phone adds, we see upside to our postpaid phone add estimate of 400K with consensus at 450K,\" J.P. Morgan says. It's not expecting guidance increases, but there's \"ample opportunity for growth in fixed wireless, enterprise and rural markets, and the company highlighted $60B of buyback potential from 2023-2025 (we model ~$40B over that time frame due to spectrum purchases).\"</li><li>Another highly rated short-term pick is Charter Communications(NASDAQ:CHTR). Itsfirst-quarter report showed solid broadband and customer relationship growth, and despite competition fears in broadband, Charter is well positioned to keep growing penetration \"driven by its market-growth strategy and new home builds - both greenfield and fill-ins.\"</li><li>It's staying a top idea across J.P. Morgan's coverage on further broadband share gains, ongoing EBITDA growth (margin expansion), strong capital returns and ramping free cash flow generation.</li><li>Turning to its least favorite names on the spectrum, there's Cable One(NYSE:CABO), where multiples are already very high compared to public peers. Preliminary results showed EBITDA strength, unsurprising due to residential momentum, operating efficiency and synergy realization. But it's struggling with a valuation of 16.8x 2022 enterprise value/EBITDA and a 3.2% free cash flow yield, vs. pure-play peers like Charter and Altice USA (ATUS; EV/EBITDA&nbsp;multiples of 10.8x and 8.6x respectively).</li><li>Another least-favorite is Gogo(NASDAQ:GOGO)- where it's modeling an entire convertible issue converting to equity, diluting existing shareholders. Total revenues are set to improve after bottoming in Q2 2020, but it's still \"wary\" as it sees a 5G network buildout pushed out to 2022, allowing for a competitor to come in. That and the potential dilution are set to weigh on the shares for the \"foreseeable future.\"</li><li>And another name in disfavor is Lumen Technologies(NYSE:LUMN), which saw a heavy run-up in January after being heavily shorted. That squeeze is \"unsustainable,\" J.P. Morgan says.&nbsp;And it's wary about the loss of subsidies for rural connectivity. \"We struggle to become positive on the name due to falling CAF/RDOF (Connect America Fund/Rural Digital Opportunity Fund) support in 2022, where Lumen will lose nearly all of its current ~$500m CAF revenue from 2021 to 2022, at ~100% EBITDA flow-thru.\"</li><li>Lumen is still spending to enable the homes it got in the CAF-II auction, but J.P. Morgan says capital expenditures should be shifted to other parts of the business rather than just going to free cash flow generation.</li></ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J.P. Morgan's short-term look finds picks, pans in telecom/pay TV</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ.P. Morgan's short-term look finds picks, pans in telecom/pay TV\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-04 14:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3689866-jp-morgans-short-term-look-finds-picks-pans-in-telecompay-tv><strong>seeking alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>J.P. Morgan's \"Spectrum of Opportunity\" note offers a chance to re-rank telecom and pay television stocks for May performance -updating its longer-term ratings with the prospect of benefiting from ...</p>\n\n<a href=\"https://seekingalpha.com/news/3689866-jp-morgans-short-term-look-finds-picks-pans-in-telecompay-tv\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3689866-jp-morgans-short-term-look-finds-picks-pans-in-telecompay-tv","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143573807","content_text":"J.P. Morgan's \"Spectrum of Opportunity\" note offers a chance to re-rank telecom and pay television stocks for May performance -updating its longer-term ratings with the prospect of benefiting from shorter-term catalysts (including such things as seasonality).And turning to its top picks for May yields several names worthy of some catalyst-based attention (based on a points system it assigns to sort out how to weigh alternatives).One is Comcast(NASDAQ:CMCSA), which is likely to keep seeing strong cable trends along with re-opening data points for its parks and film operations. It likes the stock long-term relative to megacap peers AT&T(NYSE:T)and Verizon(NYSE:VZ)\"due to strong fundamentals at cable and an improving backdrop at NBC/Sky.\" The broader market is concerned about growing broadband competition, but Comcast's trends are staying strong driven by acquisition and churn as it grows share.Meanwhile, theme park demand is ramping, with open parks breaking even during the first quarter, and there's upside to NBC/consolidated EBITDA for 2021. It has a $62 price target.On a slightly different time frame is T-Mobile (TMUS; reporting after the close tomorrow): It's the firm's best long-term idea (based on substantial operating efficiencies and cash flow growth for coming years), and while it's not looking for a big Q1 beat, it's still a short-term pick.\"After a strong quarter by AT&T but soft one from Verizon on postpaid phone adds, we see upside to our postpaid phone add estimate of 400K with consensus at 450K,\" J.P. Morgan says. It's not expecting guidance increases, but there's \"ample opportunity for growth in fixed wireless, enterprise and rural markets, and the company highlighted $60B of buyback potential from 2023-2025 (we model ~$40B over that time frame due to spectrum purchases).\"Another highly rated short-term pick is Charter Communications(NASDAQ:CHTR). Itsfirst-quarter report showed solid broadband and customer relationship growth, and despite competition fears in broadband, Charter is well positioned to keep growing penetration \"driven by its market-growth strategy and new home builds - both greenfield and fill-ins.\"It's staying a top idea across J.P. Morgan's coverage on further broadband share gains, ongoing EBITDA growth (margin expansion), strong capital returns and ramping free cash flow generation.Turning to its least favorite names on the spectrum, there's Cable One(NYSE:CABO), where multiples are already very high compared to public peers. Preliminary results showed EBITDA strength, unsurprising due to residential momentum, operating efficiency and synergy realization. But it's struggling with a valuation of 16.8x 2022 enterprise value/EBITDA and a 3.2% free cash flow yield, vs. pure-play peers like Charter and Altice USA (ATUS; EV/EBITDA multiples of 10.8x and 8.6x respectively).Another least-favorite is Gogo(NASDAQ:GOGO)- where it's modeling an entire convertible issue converting to equity, diluting existing shareholders. Total revenues are set to improve after bottoming in Q2 2020, but it's still \"wary\" as it sees a 5G network buildout pushed out to 2022, allowing for a competitor to come in. That and the potential dilution are set to weigh on the shares for the \"foreseeable future.\"And another name in disfavor is Lumen Technologies(NYSE:LUMN), which saw a heavy run-up in January after being heavily shorted. That squeeze is \"unsustainable,\" J.P. Morgan says. And it's wary about the loss of subsidies for rural connectivity. \"We struggle to become positive on the name due to falling CAF/RDOF (Connect America Fund/Rural Digital Opportunity Fund) support in 2022, where Lumen will lose nearly all of its current ~$500m CAF revenue from 2021 to 2022, at ~100% EBITDA flow-thru.\"Lumen is still spending to enable the homes it got in the CAF-II auction, but J.P. Morgan says capital expenditures should be shifted to other parts of the business rather than just going to free cash flow generation.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101165452,"gmtCreate":1619863717376,"gmtModify":1704335863329,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/101165452","repostId":"1142063705","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109848106,"gmtCreate":1619685663105,"gmtModify":1704727989154,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109848106","repostId":"1183966356","repostType":4,"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139371588,"gmtCreate":1621596563444,"gmtModify":1704360277216,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/139371588","repostId":"1139943283","repostType":4,"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101165547,"gmtCreate":1619863704989,"gmtModify":1704335863166,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/101165547","repostId":"1142063705","repostType":4,"isVote":1,"tweetType":1,"viewCount":326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359781660,"gmtCreate":1616423977350,"gmtModify":1704793967675,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/359781660","repostId":"1115438167","repostType":4,"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359983001,"gmtCreate":1616320181403,"gmtModify":1704792886901,"author":{"id":"3575490875523733","authorId":"3575490875523733","authorIdStr":"3575490875523733","name":"Where2invest","avatar":"https://static.tigerbbs.com/fa0b9be6f085e41b7680a1e1fa28fe6d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575490875523733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/359983001","repostId":"1117450855","repostType":4,"repost":{"id":"1117450855","pubTimestamp":1616166767,"share":"https://ttm.financial/m/news/1117450855?lang=&edition=fundamental","pubTime":"2021-03-19 23:12","market":"us","language":"en","title":"Powell says Fed will keep supporting economy ‘for as long as it takes’","url":"https://stock-news.laohu8.com/highlight/detail?id=1117450855","media":"marketwatch","summary":"Outlook is brightening, but recovery ‘far from complete,’ Fed chairman says in WSJ op-ed.Federal Reserve Chairman Jerome Powell on Friday said that while the U.S. economic outlook is “brightening,” the recovery is “far from complete.”In an op-ed published in the Wall Street Journal,Powell recounted the moment last February when he realized that the coronavirus pandemic would sweep across the country.“The danger to the U.S. economy was grave. The challenge was to limit the severity and duration o","content":"<blockquote>\n <b>Outlook is brightening, but recovery ‘far from complete,’ Fed chairman says in WSJ op-ed.</b>\n</blockquote>\n<p>Federal Reserve Chairman Jerome Powell on Friday said that while the U.S. economic outlook is “brightening,” the recovery is “far from complete.”</p>\n<p>In an op-ed published in the Wall Street Journal,Powell recounted the moment last February when he realized that the coronavirus pandemic would sweep across the country.</p>\n<p>“The danger to the U.S. economy was grave. The challenge was to limit the severity and duration of the fallout to avoid longer-run damage,” he said.</p>\n<p>Powell and his colleagues engineered a rapid response to the crisis, based on the lesson learned from slow recovery to the Great Recession of 2008-2009 that swift action might have been better.</p>\n<p>The central bank quickly slashed its policy interest rate to zero and launched an open-ended asset purchase program known as quantitative easing.</p>\n<p>With economists penciling in strong growth for 2021 and more Americans getting vaccinated every day, financial markets are wondering how long Fed support will last.</p>\n<p>In the op-ed, Powell said the situation “is much improved.”</p>\n<p>“But the recovery is far from complete, so at the Fed we will continue to provide the economy with the support that it needs for as long as it takes,” Powell said.</p>\n<p>“I truly believe that we will emerge from this crisis stronger and better, as we have done so often before,” he said.</p>\n<p>On Wednesday, the Fed recommitted to its easy money policy stance at its latest policy meeting despite a forecast for stronger economic growth and higher inflation this year.</p>\n<p>The Fed chairman did not mention the outlook for inflation in his Friday article . Many on Wall Street are worried that the economy will overheat before the Fed pulls back its easy policy stance.</p>\n<p>Yields on the 10-year Treasury noteTMUBMUSD10Y,1.734%have risen to 1.73% this week after starting the year below 1%.</p>\n<p>Stocks were trading lower on Friday, with the Dow Jones Industrial AverageDJIA,-0.71%down 187 points in mid-morning trading.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Powell says Fed will keep supporting economy ‘for as long as it takes’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPowell says Fed will keep supporting economy ‘for as long as it takes’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-19 23:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/powell-says-fed-will-keep-supporting-economy-for-as-long-as-it-takes-11616165178?mod=home-page><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Outlook is brightening, but recovery ‘far from complete,’ Fed chairman says in WSJ op-ed.\n\nFederal Reserve Chairman Jerome Powell on Friday said that while the U.S. economic outlook is “brightening,” ...</p>\n\n<a href=\"https://www.marketwatch.com/story/powell-says-fed-will-keep-supporting-economy-for-as-long-as-it-takes-11616165178?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/powell-says-fed-will-keep-supporting-economy-for-as-long-as-it-takes-11616165178?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1117450855","content_text":"Outlook is brightening, but recovery ‘far from complete,’ Fed chairman says in WSJ op-ed.\n\nFederal Reserve Chairman Jerome Powell on Friday said that while the U.S. economic outlook is “brightening,” the recovery is “far from complete.”\nIn an op-ed published in the Wall Street Journal,Powell recounted the moment last February when he realized that the coronavirus pandemic would sweep across the country.\n“The danger to the U.S. economy was grave. The challenge was to limit the severity and duration of the fallout to avoid longer-run damage,” he said.\nPowell and his colleagues engineered a rapid response to the crisis, based on the lesson learned from slow recovery to the Great Recession of 2008-2009 that swift action might have been better.\nThe central bank quickly slashed its policy interest rate to zero and launched an open-ended asset purchase program known as quantitative easing.\nWith economists penciling in strong growth for 2021 and more Americans getting vaccinated every day, financial markets are wondering how long Fed support will last.\nIn the op-ed, Powell said the situation “is much improved.”\n“But the recovery is far from complete, so at the Fed we will continue to provide the economy with the support that it needs for as long as it takes,” Powell said.\n“I truly believe that we will emerge from this crisis stronger and better, as we have done so often before,” he said.\nOn Wednesday, the Fed recommitted to its easy money policy stance at its latest policy meeting despite a forecast for stronger economic growth and higher inflation this year.\nThe Fed chairman did not mention the outlook for inflation in his Friday article . Many on Wall Street are worried that the economy will overheat before the Fed pulls back its easy policy stance.\nYields on the 10-year Treasury noteTMUBMUSD10Y,1.734%have risen to 1.73% this week after starting the year below 1%.\nStocks were trading lower on Friday, with the Dow Jones Industrial AverageDJIA,-0.71%down 187 points in mid-morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":217,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}